Opaleye Management Inc. 的 Form 4 申報
Protara Therapeutics, Inc.（TARA），2021/12/20 申報
- 申報編號
- 0001493152-21-032025
- 申報時間
- 2021/12/20
- 交易日
- 2021/12/16-12/17
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 4 筆非衍生性交易。公開市場買進合計 $6.69 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/12/16 | Common Stock, par value $0.001 per share | P買進取得 | +6,500 | $6.41F3 | +$41,665 | 2,493,206 | 間接 | |
| 2021/12/16 | Common Stock, par value $0.001 per share | P買進取得 | +1,063 | $6.41F3 | +$6,813.83 | 103,710 | 間接 | |
| 2021/12/17 | Common Stock, par value $0.001 per share | P買進取得 | +2,300 | $6.60F4 | +$15,180 | 2,495,506 | 間接 | |
| 2021/12/17 | Common Stock, par value $0.001 per share | P買進取得 | +490 | $6.60F4 | +$3,234 | 104,200 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F3
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.41. The range of purchase prices on the transaction date was $6.35 to $6.49 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
表 I 有 2 筆交易的價格引用這則附註。
- F4
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $ 6.60. The range of purchase prices on the transaction date was $6.40 to $6.70 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
表 I 有 2 筆交易的價格引用這則附註。